Company Filing History:
Years Active: 2012-2013
Title: The Innovations of Daeyoung Jeong: Advancements in CNS Therapeutics
Introduction
Daeyoung Jeong is a prominent inventor based in Daejeon, South Korea, known for his contributions to the field of pharmacology. With a focus on developing novel therapeutic agents for central nervous system (CNS) disorders, Jeong has been instrumental in advancing our understanding of dopamine D4 receptor antagonists. His innovative approaches have led to significant advancements in pharmaceutical compositions that can potentially improve mental health treatment options.
Latest Patents
Daeyoung Jeong holds two patents that reflect his commitment to innovation in the medical and pharmaceutical fields. His latest patents include "Piperazinyl-propyl-pyrazole derivatives as dopamine D4 receptor antagonists, and pharmaceutical compositions containing the same." This invention details a novel piperazinyl-propyl-pyrazole derivative, which exhibits superior selective affinity for the dopamine D4 receptor. It has been shown to effectively inhibit psychotic behavior induced by apomorphine while having relatively low adverse effects in testing. This discovery paves the way for developing therapeutic agents aimed at treating various CNS disorders, including schizophrenia, attention deficit hyperactivity disorder, depression, and more.
Career Highlights
Daeyoung Jeong is currently associated with the Korea Research Institute of Chemical Technology, where he continues to contribute to groundbreaking research in medicinal chemistry. His work is characterized by a rigorous approach to tackling complex health issues related to mental illnesses, which highlights his role as an innovator and researcher in the pharmaceutical industry.
Collaborations
Throughout his career, Daeyoung Jeong has collaborated with esteemed colleagues, including Jae Yang Kong and Woo-Kyu Park. These partnerships enhance the collaborative spirit within the research community and further drive innovations in drug development and therapeutic solutions.
Conclusion
Daeyoung Jeong's innovative contributions, particularly in the realm of dopamine D4 receptor antagonists, mark significant progress in the fight against CNS disorders. His dedication to research at the Korea Research Institute of Chemical Technology exemplifies the impact that inventors can have on advancing medical science and improving the quality of life for individuals suffering from mental health challenges.